The Certification Matters: A Comparative Performance Analysis of Combat Application Tourniquets versus Non-Certified CAT Look-Alike Tourniquets.

Stop the Bleed bleeding hemorrhage prehospital tourniquet

Journal

Prehospital and disaster medicine
ISSN: 1945-1938
Titre abrégé: Prehosp Disaster Med
Pays: United States
ID NLM: 8918173

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 23 8 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

The Stop the Bleed campaign provided civilians with tourniquet application training and increased the demand for tourniquets among the general population, which led to the development of new commercially available devices. However, most widely available tourniquets have not undergone testing by regulatory bodies and their efficacy remains unknown. This study aimed to compare the efficacy and performance of Combat Application Tourniquets (CAT) versus uncertified tourniquets. This study compared 25 CAT with 50 commercially available "look-alike" tourniquets (LA-TQ) resembling the CAT. The CAT and the LA-TQ were compared for cost, size, and tested during one-hour and six-hour applications on a manikin's leg. The outcomes were force applied, force variation during the application, and tourniquet rupture rate. The LA-TQ were cheaper (US$6.07 versus US$27.19), shorter, and had higher inter-device variability than the CAT (90.1 [SE = 0.5] cm versus 94.5 [SE = 0.1] cm; P <.001). The CAT applied a significantly greater force during the initial application when compared to the LA-TQ (65 [SE = 3] N versus 14 [SE = 1] N; P <.001). While the initial application force was maintained for up to six hours in both groups, the CAT group applied an increased force during one-hour applications (group effect: F [1,73] = 105.65; P <.001) and during six-hour applications (group effect: F [1,12] = 9.79; P = .009). The rupture rate differed between the CAT and the LA-TQ (0% versus 4%). The LA-TQ applied a significantly lower force and had a higher rupture rate compared to the CAT, potentially affecting tourniquet performance in the context of public bleeding control. These findings warrant increased layperson education within the framework of the Stop the Bleed campaign and further investigations on the effectiveness of uncertified devices in real-world applications.

Identifiants

pubmed: 37605860
pii: S1049023X23006076
doi: 10.1017/S1049023X23006076
doi:

Types de publication

Journal Article

Langues

eng

Pagination

450-455

Auteurs

Emanuele Lagazzi (E)

Department of Surgery, Humanitas Research Hospital, Rozzano, Lombardia, Italy.
Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsUSA.
Italian Trauma League ODV, Genova, Italy.

Giulia Ballardini (G)

Department of Informatics, Bioengineering, Robotics, and Systems Engineering, University of Genova, Genova, Italy.
Max Planck Institute for Intelligent Systems, Stuttgart, Germany.

Alberto Drogo (A)

Italian Trauma League ODV, Genova, Italy.
School of Medical and Pharmaceutical Sciences, University of Genova, Genova, Italy.

Ludovica Viola (L)

Department of Informatics, Bioengineering, Robotics, and Systems Engineering, University of Genova, Genova, Italy.

Eva Marrone (E)

Italian Trauma League ODV, Genova, Italy.
School of Medical and Pharmaceutical Sciences, University of Genova, Genova, Italy.

Valerio Valente (V)

Italian Trauma League ODV, Genova, Italy.
Department of Anesthesia and Intensive Care Unit, University of Modena and Reggio Emilia, Modena, Emilia-Romagna, Italy.

Michele Bonetti (M)

Italian Trauma League ODV, Genova, Italy.
Schwarzwald-Baar Klinikum, University Hospital of the University of Freiburg - Division of Anesthesia and Intensive - Emergency and Pain Medicine Villingen-Schwenningen, Freiburg, Baden-Württemberg, Germany.

Jarone Lee (J)

Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsUSA.

David R King (DR)

Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsUSA.

Serena Ricci (S)

Department of Informatics, Bioengineering, Robotics, and Systems Engineering, University of Genova, Genova, Italy.
Simulation and Advanced Education Center, University of Genova, Genova, Liguria, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH